Who owns the ASSERTIO SPECIALTY PHARMACEUTICALS trademark?

The ASSERTIO SPECIALTY PHARMACEUTICALS trademark is owned by Assertio Therapeutics, Inc..

What class is the ASSERTIO SPECIALTY PHARMACEUTICALS trademark registered in?

The ASSERTIO SPECIALTY PHARMACEUTICALS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ASSERTIO SPECIALTY PHARMACEUTICALS?

The USPTO serial number for ASSERTIO SPECIALTY PHARMACEUTICALS is 99084137.

What is the registration number for ASSERTIO SPECIALTY PHARMACEUTICALS?

ASSERTIO SPECIALTY PHARMACEUTICALS is registered under USPTO registration number 0.

ASS

USPTO Trademark Record

PENDING

ASSERTIO SPECIALTY PHARMACEUTICALS

SN 99084137·Reg 0·Filed Mar 14, 2025

Owner Assertio Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ASSERTIO SPECIALTY PHARMACEUTICALS (Serial No. 99084137), Registration No. 0, is a pending US trademark filed on Mar 14, 2025 by Assertio Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

ASSERTIO SPECIALTY PHARMACEUTICALS (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 14, 2025

SERIAL

99084137

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Assertio Therapeutics, Inc.

Entity

Corporation

State

Address

100 SOUTH SAUNDERS ROAD, Suite 300, Lake Forest, IL, 60045

Country

Attorney

NameTim Burgdorf

Law firm

Tim Burgdorf Global Patent Group, LLC

Docket

Assertio - ASP

Address

2275 Cassens Drive, Suite 118, Fenton, MO 63026-0000, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateMar 14, 2025

Serial Number99084137

Registration No.0

Registration DateDec 31, 1969

Status DateAug 05, 2026

Published for OppositionSep 16, 2025

Mark TypeStandard characters

Attorney DocketAssertio - ASP

Status DescriptionLive and pending, statement of use registration review complete

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Dec 23, 2025

First use in commerce: Dec 23, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

18 events

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 05, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 05, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

STATEMENT OF USE PROCESSING COMPLETE

Jul 21, 2026

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

May 11, 2026

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 11, 2026

USE AMENDMENT FILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 11, 2025

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Sep 16, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 16, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 10, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Aug 19, 2025

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Aug 19, 2025

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Aug 19, 2025

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Aug 19, 2025

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 19, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Aug 14, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION ENTERED

Mar 14, 2025

NEW APPLICATION ENTERED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 14, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 14, 2025

APPLICATION FILING RECEIPT MAILED

ASSERTIO SPECIALTY PHARMACEUTICALS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Assertio Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tim Burgdorf

Resources

Company